Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axfood AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 51.38B | 21.7x | 2.6 | SEK 233.70 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
Viva Wine AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 3.55B | 30.9x | -1.37 | SEK 39.50 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.8% Upside | Upgrade to Pro+ | |
EQL Pharma | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 2.12B | 68.2x | 4.08 | SEK 73 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11% Downside | Upgrade to Pro+ | |
AcuCort | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 105.11M | -2.7x | -0.17 | SEK 0.72 | -18.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Newbury Pharmaceuticals AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 81.51M | -5.4x | -0.19 | SEK 3.44 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harm Reduction AB | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 15.83M | -0.4x | 0 | SEK 0.05 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |